Trending stocks today
Cullinan Oncology, Inc. (CGEM-Q)
NASDAQ:CGEM
19.60
0.74
(3.92%) 1d
Financials
Technical Analysis
This summary was created by AI, based on 2 opinions in the last 12 months.
Cullinan Oncology, Inc. (CGEM-Q) has had mixed reviews from experts. While one expert recommended covering the position due to a net investment loss of 27%, another expert reiterated it as a top pick, citing the company's focus on oncology therapies, growing pipeline of prospects, and strong financials. The stock is currently trading under book value with a 14% ROE. However, the stop is recommended to be maintained at $8.50, with an upside potential of 36%. The analysts’ price target is $29.00, but the stock has triggered its stop at $8.50. Overall, the stock is experiencing volatility and conflicting opinions from experts.
$8.170
Unknown
We reiterate this biopharma company focused on oncology therapies, as a TOP PICK. Pilot projects are continuing to advance and they have a growing pipeline of new prospects. It trades under book value, supporting a 14% ROE. Cash reserves are growing, while debt is retired. We recommend maintaining the stop at $8.50, looking to achieve $17.00 -- upside of 36%. Yield 0%
(Analysts’ price target is $29.00)CGEM is a unique pharmaceutical company that collaborates with other developers and academia to develop drugs to help cancer patients. It has six on-going products in its pipeline. It trades below book value, at 6x earnings, and supports a 19% ROE. We like that it is low beta compared to the market. We recommend a stop-loss at $8.50, looking to achieve $17 — upside potential of 50%. Yield 0%
(Analysts’ price target is $28.75)- «
- ‹
- 1
- ›
- »
Cullinan Oncology, Inc.(CGEM-Q) Rating
Ranking : 4 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 1
Cullinan Oncology, Inc.(CGEM-Q) Frequently Asked Questions
What is Cullinan Oncology, Inc. stock symbol?
Cullinan Oncology, Inc. is a American stock, trading under the symbol CGEM-Q on the NASDAQ (CGEM). It is usually referred to as NASDAQ:CGEM or CGEM-Q
Is Cullinan Oncology, Inc. a buy or a sell?
In the last year, 1 stock analyst published opinions about CGEM-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Cullinan Oncology, Inc..
Is Cullinan Oncology, Inc. a good investment or a top pick?
Cullinan Oncology, Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Cullinan Oncology, Inc..
Why is Cullinan Oncology, Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Cullinan Oncology, Inc. worth watching?
In the last year, there was no coverage of Cullinan Oncology, Inc. published on Stockchase.
What is Cullinan Oncology, Inc. stock price?
On 2024-08-30, Cullinan Oncology, Inc. (CGEM-Q) stock closed at a price of $19.6.
Our PAST TOP PICK with CGEM has triggered its stop at $8.50. To remain disciplined, we recommend covering the position at this time. This will result in a net investment loss of 27%, when combined with previous recommendations.